Ft. Smith, Arkansas (PRWEB) August 7, 2006
Does herpes have to last forever? Not according to Dr. Allan Fjeistrup, M.D. of Stavanger, Norway.
Dr. Fjeistrup has now administered a new protocol developed by Imulux to 100 of his patients in Norway and over 200 participants of a clinical trial conducted in Henderson, Nevada. All of these patients were suffering from genital, oral or shingles, also a herpes virus.
“They seem to clear up overnight” he said. According to Dr. Fjeistrup “It uses a proprietary, newly patented, non-invasive technique to teach the herpes victim’s own immune system to recognize the invading virus which allows the body to create antibodies.”
Earlier clinical trials conducted in Sarasota, Florida indicate 100% success for immediate relief of symptoms and expedited healing. Two years later after application of the patented Imulux protocol the continued remission rates exceed 93%.
“You can catch another viral strain, but the original treated virus should never return” according to Dr. Jon Stoneburner, the developer of this new “miracle”.
The United States FDA (Food and Drug Administration) has granted an IND (Investigational New Drug) application to further test the efficacy of this protocol.
Imulux wishes to offer a one million dollar reward to any scientist, researcher, institution or even individual that can prove that the Imulux protocol does not work.